Browsing by Author "Alías i Ferri, María"

Sort by: Order: Results:

  • A gender perspective of addictive disorders
    Fonseca Casals, Francina, 1972-; Robles-Martínez, María; Tirado Muñoz, Judit; Alías i Ferri, María; Mestre-Pintó, Juan Ignacio; Coratu, Ana Maria; Torrens, Marta (Springer, 2021)
    Purpose of review: Substance use disorders (SUD) affect differentially women and men. Although the prevalence has been reported higher in men, those women with addictive disorders present a more vulnerable profile and are ...
  • Alcohol induced depression: clinical, biological and genetic features
    Farré Martínez, Adriana; Tirado Muñoz, Judit; Spataro, Nino; Alías i Ferri, María; Torrens, Marta; Fonseca Casals, Francina, 1972- (MDPI, 2020)
    Background: In clinical practice, there is the need to have clinical and biological markers to identify induced depression. The objective was to investigate clinical, biological and genetic differences between Primary Major ...
  • CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial
    Mestre-Pintó, Juan Ignacio; Fonseca Casals, Francina, 1972-; Schaub, M. P.; Baumgartner, Christian F.; Alías i Ferri, María; Torrens, Marta (BioMed Central, 2022)
    Background: cannabis is the most-frequently used illicit drug in Europe. Over the last few years in Spain, treatment demand has increased, yet most cannabis users do not seek treatment despite the related problems. A ...
  • New psychoactive substances consumption in opioid-use disorder patients
    Alías i Ferri, María; Pellegrini, Manuela; Marchei, Emilia; Pacifici, Roberta; Rotolo, Maria Concetta; Pichini, Simona; Pérez Mañá, Clara; Papaseit Fontanet, Esther; Muga, Roberto; Fonseca Casals, Francina, 1972-; Torrens, Marta; Farré Albaladejo, Magí (MDPI, 2022)
    (1) Background: Since the beginning of the 21st century, the large number and wide chemical variety of new psychoactive substances (NPS) that enter the market every year has become a public health problem. Given the rapidity ...
  • New synthetic opioids use among patients in treatment for an Opioid Use Disorder in Barcelona
    Alías i Ferri, María; Marchei, Emilia; Pacifici, Roberta; Pichini, Simona; Pellegrini, Manuela; Pérez Mañá, Clara; Papaseit Fontanet, Esther; Muga, Roberto; Fonseca Casals, Francina, 1972-; Farré Albaladejo, Magí; Torrens, Marta (Karger (S. Karger AG), 2022)
    Introduction: New synthetic opioids (NSO), a class of new psychoactive substances (NPS), have recently emerged and pose an upcoming global public health challenge. The effects produced by NSO are similar to those from ...
  • Trastorno por uso de cocaína y depresión: cuando el diagnóstico clínico no es suficiente
    Alías i Ferri, María; García-Marchena, Nuria; Mestre-Pintó, Juan Ignacio; Araos, Pedro; Vergara-Moragues, Esperanza; Fonseca Casals, Francina, 1972-; González-Saiz, Francisco; Rodríguez de Fonseca, Fernando; Torrens, Marta; The NEURODEP Group (Socidrogalcohol, 2021)
    Antecedentes: El consumo de cocaína es un creciente problema de salud en todo el mundo. Además, los pacientes con trastorno por consumo de cocaína (TCC) presentan una alta comorbilidad con el trastorno depresivo mayor ...